Deuterated caffeine and uses thereof
Abstract
Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.
Claims
exact text as granted — not AI-modified1 - 2 . (canceled)
3 . A cosmetic composition comprising a compound of Formula (I):
or an acceptable salt thereof;
wherein each Y is independently hydrogen or deuterium; and
at least one Y is deuterium.
4 . (canceled)
5 . The composition of claim 3 , wherein the composition is suitable for administration by injection, absorption, or implantation.
6 . The composition of claim 3 , wherein the composition is suitable for topical administration.
7 - 14 . (canceled)
15 . The composition of claim 3 , wherein at least three instances of Y are deuterium.
16 - 20 . (canceled)
21 . The composition of claim 3 , wherein nine instances of Y are deuterium.
22 . The composition of claim 3 , wherein each Y is deuterium.
23 - 30 . (canceled)
31 . The composition of claim 3 , wherein the compound is selected from the group consisting of:
or a pharmaceutically or nutraceutically acceptable salt thereof.
32 . The composition of claim 3 , wherein the compound is
or a pharmaceutically or nutraceutically acceptable salt thereof.
33 . The composition of claim 3 , wherein the compound is
or a pharmaceutically or nutraceutically acceptable salt thereof.
34 . The composition of claim 3 , wherein the compound is selected from the group consisting of:
35 . The composition of claim 3 , wherein the compound is
36 . The composition of claim 3 , further comprising a pharmaceutically or nutraceutically acceptable carrier.
37 . (canceled)
38 . The composition of claim 6 , wherein the topical composition is a shampoo, conditioner, cream, foam, gel, lotion, ointment, transdermal patch, tincture, or paste.
39 . (canceled)
40 . The composition of claim 3 , further comprising an additional agent.
41 - 49 . (canceled)
50 . The composition of claim 3 , wherein the composition comprises about 1 mg to about 10,000 mg of the compound of Formula (I), or a salt thereof.
51 . The composition of claim 50 , wherein the composition comprises about 1 mg to about 1,000 mg of the compound of Formula (I), or a pharmaceutically or nutraceutically acceptable salt thereof.
52 . The composition of claim 50 , wherein the composition comprises about 1 mg to about 100 mg of the compound of Formula (I), or a pharmaceutically or nutraceutically acceptable salt thereof.
53 . The composition of claim 3 , wherein the composition comprises about 1 mg/ml to about 100 mg/ml of the compound of Formula (I), or a pharmaceutically or nutraceutically acceptable salt thereof.
54 . The composition of claim 53 , wherein the composition comprises about 1 mg/ml to about 50 mg/ml of the compound of Formula (I), or a pharmaceutically or nutraceutically acceptable salt thereof.
55 . The composition of claim 53 , wherein the composition comprises about 5 mg/ml to about 15 mg/ml of the compound of Formula (I), or a pharmaceutically or nutraceutically acceptable salt thereof.
56 - 140 . (canceled)Join the waitlist — get patent alerts
Track US2023371555A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.